• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

Download Free Sample

Leave This Empty:

Migraine Therapeutics Market, Global Outlook and Forecast 2023-2032

The global Migraine Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Migraines are a family of recurrent attacks.The symptom is paroxysmal unilateral throbbing headache, accompanied by nausea, vomiting and confusion. Migraine therapeutics includes triptans, acetylcholine inhibitors/neurotoxins, ergot alkaloids, nsaids, ditan, CGRP small molecule antagonists, CGRP monoclonal antibodies, etc.
This report aims to provide a comprehensive presentation of the global market for Migraine Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Therapeutics. This report contains market size and forecasts of Migraine Therapeutics in global, including the following market information:

  • Global Migraine Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
  • Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Specific Anti-migraine Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Migraine Therapeutics include Allergan, Merck, Pfizer, Teva, Amgen, Johnson & Johnson, Endo International, GlaxoSmithKline and Impax, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Migraine Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Migraine Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Migraine Therapeutics Market Segment Percentages, by Type, 2022 (%)
  • Specific Anti-migraine Drugs
  • Acute Therapies
  • Preventative Therapies
  • Other
Global Migraine Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Migraine Therapeutics Market Segment Percentages, by Application, 2022 (%)
  • Hospitals
  • Clinics
  • Household Use
  • Others
Global Migraine Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Migraine Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis

The report also provides analysis of leading market participants including:
  • Key companies Migraine Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Migraine Therapeutics revenues share in global market, 2022 (%)

key players include:

  • Allergan
  • Merck
  • Pfizer
  • Teva
  • Amgen
  • Johnson & Johnson
  • Endo International
  • GlaxoSmithKline
  • Impax
  • Abbott
  • Bayer
  • Eli Lilly
  • Novartis International
  • Ethypharm
  • Kowa Pharmaceuticals America
  • Winston Pharmaceuticals
  • AstraZeneca
  • Amirall
  • OptiNose
  • Revance Therapeutics
  • RedHill Biopharma
  • Bausch Health
  • NeurAxon
  • Biohaven Pharma
  • Eisai
  • Valeant Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Migraine Therapeutics, market overview.
Chapter 2: Global Migraine Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Migraine Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Migraine Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.